Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (111-120 of 528) with videos related to

Pageof 53
Sort By:
Journal of Molecular Biology|June 19, 2015
Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of PaxillinMalgorzata Nocula-Lugowska, Mateusz Lugowski, Ravi Salgia, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 8, 2003
Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancerNazia F Jafri, Patrick C Ma, Gautam Maulik, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
MET receptor tyrosine kinaseLeonardo Faoro, Gustavo M Cervantes, Essam El-Hashani, et al.
Seminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.
Cell Reports. Medicine|February 1, 2021
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, et al.
Oncotarget|February 9, 2017
Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experienceJun Gong, May Cho, Marvin Sy, et al.
Oncotarget|April 13, 2018
Value-based genomicsJun Gong, Kathy Pan, Marwan Fakih, et al.
Cancer Treatment and Research|August 23, 2025
Cancer Immunotherapy-An OverviewPrakash Kulkarni, Dana Do, Sagun Shrestha, et al.
Oncotarget|March 17, 2016
FAK and paxillin, two potential targets in pancreatic cancerRajani Kanteti, Surinder K Batra, Frances E Lennon, et al.
Cancer Treatment Reviews|April 26, 2020
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skippingRavi Salgia, Martin Sattler, Juergen Scheele, et al.
Pageof 53

Showing results (111-120 of 528) with videos related to

Sort By:
Pageof 53
Journal of Molecular Biology|June 19, 2015
Engineering Synthetic Antibody Inhibitors Specific for LD2 or LD4 Motifs of PaxillinMalgorzata Nocula-Lugowska, Mateusz Lugowski, Ravi Salgia, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|October 8, 2003
Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancerNazia F Jafri, Patrick C Ma, Gautam Maulik, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
MET receptor tyrosine kinaseLeonardo Faoro, Gustavo M Cervantes, Essam El-Hashani, et al.
Seminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.
Cell Reports. Medicine|February 1, 2021
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, et al.
Oncotarget|February 9, 2017
Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experienceJun Gong, May Cho, Marvin Sy, et al.
Oncotarget|April 13, 2018
Value-based genomicsJun Gong, Kathy Pan, Marwan Fakih, et al.
Cancer Treatment and Research|August 23, 2025
Cancer Immunotherapy-An OverviewPrakash Kulkarni, Dana Do, Sagun Shrestha, et al.
Oncotarget|March 17, 2016
FAK and paxillin, two potential targets in pancreatic cancerRajani Kanteti, Surinder K Batra, Frances E Lennon, et al.
Cancer Treatment Reviews|April 26, 2020
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skippingRavi Salgia, Martin Sattler, Juergen Scheele, et al.
Pageof 53